secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2025-07-23T23:59:59+00:00
Accession:  0001213900-25-066819
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed grants Scilex option to repurchase Penny Warrants for up to $27M; clarifies warrant terms
--------------------------------------------------------------------------------

- Scilex pays $1.5M option fee in two installments ($750K by Aug 8, 2025; $750K by Dec 16, 2025).
- Scilex may repurchase 3.13M warrants for $13M by Sep 30, 2025, and 3.37M warrants for $14M by Dec 31, 2025.
- If all payments made, Tranche A Note maturity extends to Mar 31, 2026, and make-whole payment waived.
- Oramed clarifies Penny Warrant exercise price remains $0.01/share post 1-for-35 reverse split, not $0.35.
- Correction has no impact on financial position, results, or cash flows as of Mar 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390025066819/0001213900-25-066819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390025066819/ea0248817-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-066819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer